Ekso Bionics Holdings, Inc. held $1.2M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Ekso Bionics Holdings, Inc. has filed alongside them.
Ticker history: EKSO became CHRN (ChronoScale Holdings Corporation) on . Earlier news and filings retain their original names and dates. View EKSO history.
Annual figures, oldest first. Point at a bar to read its period.
EKSO Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | N/A | N/A | N/A | N/A | $2.0M+0.2% | $2.0M+388.7% | $407K-84.6% | $2.6M-45.2% | $4.8M+2996.2% | $156K-36.6% | $246K+90.7% | $129K | N/A | N/A |
| Cash & Equivalents | $1.2M-74.0% | $4.5M-48.0% | $8.6M-57.9% | $20.5M-49.2% | $40.4M+214.2% | $12.9M+18.3% | $10.9M+42.0% | $7.7M-72.5% | $27.8M+65.1% | $16.8M-13.8% | $19.6M-22.4% | $25.2M+3029.2% | $805K | N/A |
EKSO Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $520K | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $4.0M-50.4% | $1.2M-74.0% | $2.7M-67.2% | $5.2M-10.9% | $8.1M-8.5% | $4.5M-48.0% | $8.3M-16.6% | $5.9M-55.8% | $8.8M-45.9% | $8.6M-57.9% | $9.9M-65.9% | $13.3M-58.3% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Ekso Bionics Holdings, Inc. financials
Frequently Asked Questions
Ekso Bionics Holdings, Inc. held $1.2M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period.
Ekso Bionics Holdings, Inc. (EKSO) reported $520K in long-term debt in Q1 2026.
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Ekso Bionics Holdings, Inc. (EKSO) reported on that line in every period on record.